Acid-Degradable PEG Lipids for Stable mRNA LNP Endosome Escape
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The efficacy of solid lipid nanoparticles (SLNs) for delivering mRNA is limited by the 'PEG dilemma', where excessive PEGylation leads to lower cell uptake and endosomal disruption, despite being necessary for stability and reduced toxicity.
Innovation Solution
Development of benzaldehyde acetal acid-degradable amphiphilic lipids and self-assembling peptides that form stable lipid nanoparticles, which enhance endosome escape and balance amphiphilicity, allowing for efficient mRNA delivery by forming intracellular nanofibrils that disrupt actin filaments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If excessive PEGylation is used to maintain SLN stability and reduce toxicity, then stability and reduced toxicity are improved, but cell uptake and endosomal disruption are reduced
Solution Approach 1:
The patent employs dynamic PEGylation where the PEG-lipid composition is not static but changes in response to environmental cues. The acid-degradable acetal linker allows the PEG layer to be dynamically adjusted - stable at physiological pH for circulation, then degradable in acidic endosomes to enhance cellular uptake and endosomal escape, thus resolving the contradiction between stability and cell uptake
Solution Approach 2:
The patent changes the chemical parameter of the PEG-lipid by incorporating an acid-degradable acetal linker. This parameter change allows the PEGylation level to be modulated by pH - maintaining high PEG content for stability during circulation, then reducing effective PEGylation in acidic endosomes to improve cell uptake and endosomal disruption, thereby resolving the contradiction
2Duration of action of stationary object
If PEGylation is increased to extend half-life in physiological environment, then half-life is improved, but endosomal disruption capability is reduced
Solution Approach 1:
The patent applies preliminary action by pre-equipping the LNP with PEG-lipid to ensure stability and extended half-life during circulation. The acid-degradable acetal linker is pre-installed to enable subsequent endosomal disruption when the LNP reaches the acidic endosomal compartment, thus resolving the contradiction between extended half-life and endosomal disruption capability
Solution Approach 2:
The acid-degradable acetal linker serves as an intermediary between the PEG-lipid and the LNP core. It allows the PEG layer to act as a protective intermediary during circulation (extending half-life), then facilitates controlled disruption in acidic endosomes (enabling endosomal escape), thereby resolving the contradiction between half-life extension and endosomal disruption
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed compounds enable efficient mRNA delivery to various tissues, including muscle, lung, spleen, and blood, with enhanced transfection efficiency and targeted cellular effects, such as apoptosis or necroptosis in cancer cells.
Implementation Method 1
L1, L2 and L3 are linkers selected from a bond, an optionally substituted heteroatom and an optionally substituted C1-18 hydrocarbyl or heterohydrocarbyl, providing acid degradable linkages
Implementation Method 2
R1 comprises a self-assembling peptide or precursor, which can self-assemble after the cleavage of the acid degradable acetal linker
Implementation Method 3
benzaldehyde acetal acid-degradable amphiphilic lipid and self-assembling peptides that form stable lipid nanoparticles
Data Source
AI summary
Compounds comprising a benzaldehyde acetal acid-degradable amphiphilic lipid and self-assembling peptides are incorporated in lipid nanoparticle (LNP) and used to transfect cells.